CLINICAL TRIALS PROFILE FOR ETONOGESTREL
✉ Email this page to a colleague
All Clinical Trials for ETONOGESTREL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00369967 ↗ | Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents | Terminated | American College of Obstetricians and Gynecologists | N/A | 2007-02-01 | We hypothesize that using "quick start" initiation of the contraceptive vaginal ring in adolescents seeking birth control will improve compliance compared to traditional start. We will conduct a randomized controlled trial comparing "quick start" to traditional start initiation of the contraceptive vaginal ring in adolescents seeking birth control. The primary study outcome is method continuation at 3, 6, and 12 months. Secondary outcomes include abnormal bleeding, product satisfaction, and adverse events. |
| NCT00369967 ↗ | Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents | Terminated | Bayer | N/A | 2007-02-01 | We hypothesize that using "quick start" initiation of the contraceptive vaginal ring in adolescents seeking birth control will improve compliance compared to traditional start. We will conduct a randomized controlled trial comparing "quick start" to traditional start initiation of the contraceptive vaginal ring in adolescents seeking birth control. The primary study outcome is method continuation at 3, 6, and 12 months. Secondary outcomes include abnormal bleeding, product satisfaction, and adverse events. |
| NCT00369967 ↗ | Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents | Terminated | Virginia Commonwealth University | N/A | 2007-02-01 | We hypothesize that using "quick start" initiation of the contraceptive vaginal ring in adolescents seeking birth control will improve compliance compared to traditional start. We will conduct a randomized controlled trial comparing "quick start" to traditional start initiation of the contraceptive vaginal ring in adolescents seeking birth control. The primary study outcome is method continuation at 3, 6, and 12 months. Secondary outcomes include abnormal bleeding, product satisfaction, and adverse events. |
| NCT00403793 ↗ | Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057) | Completed | Bayer | Phase 2 | 2003-10-01 | Male volunteers receive a new hormonal contraceptive consisting of an implant releasing a hormone and hormone injections in order to investigate the suppressive effect on sperm production and reversibility of sperm production after end of treatment. |
| NCT00403793 ↗ | Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057) | Completed | Merck Sharp & Dohme Corp. | Phase 2 | 2003-10-01 | Male volunteers receive a new hormonal contraceptive consisting of an implant releasing a hormone and hormone injections in order to investigate the suppressive effect on sperm production and reversibility of sperm production after end of treatment. |
| NCT00612508 ↗ | Hormonal Contraception and Vaginal Health | Completed | Oregon Clinical and Translational Research Institute | N/A | 2007-05-01 | The purpose of this study is to help determine if the route by which women receive hormonal contraception causes different changes to occur in the lining of the vagina. The investigators plan to compare an oral route (taking birth control pills) with a vaginal route (using a vaginal ring). |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ETONOGESTREL
Condition Name
Clinical Trial Locations for ETONOGESTREL
Trials by Country
Clinical Trial Progress for ETONOGESTREL
Clinical Trial Phase
Clinical Trial Sponsors for ETONOGESTREL
Sponsor Name
